HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Minn, H. Articles by Wahl, R. L. Search for Related Content PubMed PubMed Citation Articles by Minn, H. Articles by Wahl, R. L.

In Vitro Comparison of Cell Proliferation Kinetics and Uptake of Tritiated Fluorodeoxyglucose and L-Methionine in Squamous-Cell Carcinoma of the Head and Neck

Division of Nuclear Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan
Departments of Oncology, Radiotherapy and Otolaryngology, University of Turku, Turku, Finland

Correspondence: For correspondence contact: Heikki R.I. Minn, MD, Department of Oncology and Radiotherapy, University of Turku, FIN-20520 Turku, Finland.

Correspondence: For reprints contact: Richard L. Wahl, MD, Division of Nuclear Medicine, University of Michigan Medical Center, 1500 E Medical Center Dr., B1G412, Ann Arbor, MI 48109-0028.

ABSTRACT

Estimation of tumor proliferative activity is important for the optimal management of head and neck cancer. Noninvasive metabolic imaging with PET may complement currently used cytopathologic methods to study tumor proliferation. Methods: Fluorodeoxyglucose (FDG) and L-methionine (MET) were studied for their potential to assess in vitro the growth characteristics of three squamous-cell carcinoma (SCC) cell lines established recently in patients with head and neck cancer. A time-course uptake of tritiated FDG and MET was measured over the complete growth cycle of one rapidly growing (UT-SCC-5) and two relatively slower growing (UT-SCC-1A and UT-SCC-9) cell lines. DMA flow cytometry was used for assessment of proliferative activity. Results: There was a strong linear relationship for both FDG and MET uptake versus the viable cell number although absolute MET uptake was consistently lower than that of FDG in the exponential and plateau phases of growth (p < 0.01), leading MET to underestimate cell number. The pattern of MET uptake followed the flow cytometric changes in the proliferation index (% of S + G2/M cells) in two of three cases (UT-SCC-1A and UT-SCC-5) while a similar, although clearly weaker, relationship was seen with FDG and flow cytometry findings in only one case (UT-SCC-5). Conclusion: In these three human SCC cell lines assessed in vitro, FDG is a better marker of cell viability than MET, whereas MET is superior for estimating proliferative activity. Extrapolations of these in vitro data to the interpretation of PET images should be made with caution since tumors may have confounding factors that may affect in vivo tracer uptake.

Key Words: fluorodeoxyglucose • L-methionine • flow cytometry • squamous-cell carcinoma • cell lines

This article has been cited by other articles:

				L. de Geus-Oei, B Wiering, P. Krabbe, T. Ruers, C. Punt, and W. Oyen FDG-PET for prediction of survival of patients with metastatic colorectal carcinoma Ann. Onc., November 1, 2006; 17(11): 1650 - 1655. [Abstract] [Full Text] [PDF]

				E. Bastiaannet, O. S. Hoekstra, W. J. G. Oyen, P. L. Jager, T. Wobbes, and H. J. Hoekstra Level of Fluorodeoxyglucose Uptake Predicts Risk for Recurrence in Melanoma Patients Presenting With Lymph Node Metastases Ann. Surg. Oncol., July 1, 2006; 13(7): 919 - 926. [Abstract] [Full Text] [PDF]

				A-L Grosu, M Piert, and M Molls Experience of PET for target localisation in radiation oncology Br. J. Radiol., November 1, 2005; Supplement_28(1): 18 - 32. [Full Text] [PDF]

				R. Bergmann, J. Pietzsch, F. Fuechtner, B. Pawelke, B. Beuthien-Baumann, B. Johannsen, and J. Kotzerke 3-O-Methyl-6-18F-Fluoro-L-Dopa, a New Tumor Imaging Agent: Investigation of Transport Mechanism In Vitro J. Nucl. Med., December 1, 2004; 45(12): 2116 - 2122. [Abstract] [Full Text] [PDF]

				H. Zhang, K. Yoshikawa, K. Tamura, T. Tomemori, K. Sagou, M. Tian, S. Kandatsu, T. Kamada, H. Tsuji, T. Suhara, et al. [11C]Methionine Positron Emission Tomography and Survival in Patients with Bone and Soft Tissue Sarcomas Treated by Carbon Ion Radiotherapy Clin. Cancer Res., March 1, 2004; 10(5): 1764 - 1772. [Abstract] [Full Text] [PDF]

				J. L. Schwartz, Y. Tamura, R. Jordan, J. R. Grierson, and K. A. Krohn Monitoring Tumor Cell Proliferation by Targeting DNA Synthetic Processes with Thymidine and Thymidine Analogs J. Nucl. Med., December 1, 2003; 44(12): 2027 - 2032. [Abstract] [Full Text] [PDF]

				E. Chesnay, E. Babin, J. M. Constans, D. Agostini, A. Bequignon, A. Regeasse, F. Sobrio, and S. Moreau Early Response to Chemotherapy in Hypopharyngeal Cancer: Assessment with 11C-Methionine PET, Correlation with Morphologic Response, and Clinical Outcome J. Nucl. Med., April 1, 2003; 44(4): 526 - 532. [Abstract] [Full Text] [PDF]

				A. S. Allal, P. Dulguerov, M. Allaoua, C.-A. Haenggeli, E. A. El Ghazi, W. Lehmann, and D. O. Slosman Standardized Uptake Value of 2-[18F] Fluoro-2-Deoxy-D-Glucose in Predicting Outcome in Head and Neck Carcinomas Treated by Radiotherapy With or Without Chemotherapy J. Clin. Oncol., March 1, 2002; 20(5): 1398 - 1404. [Abstract] [Full Text] [PDF]

				P. L. Jager, W. Vaalburg, J. Pruim, E. G.E. de Vries, K.-J. Langen, and D. A. Piers Radiolabeled Amino Acids: Basic Aspects and Clinical Applications in Oncology J. Nucl. Med., March 1, 2001; 42(3): 432 - 445. [Abstract] [Full Text]

				H. Sakurai, N. Mitsuhashi, K. Hayakawa, and H. Niibe Giant Cell Tumor of the Thoracic Spine Simulating Mediastinal Neoplasm AJNR Am. J. Neuroradiol., October 1, 1999; 20(9): 1723 - 1726. [Abstract] [Full Text]